Cardio Diagnostics Holdings Inc (NASDAQ:CDIO) currently has a daily average trading volume of 2.19M but it saw 234480 shares traded in last market. With a market cap of 20.33M USD, the company’s current market price of $0.39 came rising about 4.22 while comparing to the previous closing price of $0.37. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.77 and as low as $0.19. In the recent trading on the day, stock has struck highest price mark of $0.3641 while lowest mark touched by it was $0.3899.
Taking a look at 20-day trading activity of Cardio Diagnostics Holdings Inc (CDIO) gives us an average price of $0.3751, while its current price level is -77.97% below from 52-week high level whereas it is 105.21% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.4418 while that of 200 days or SMA-200 reads an average of $0.4550. A closer look into the stock’s movement over the week reveals that its volatility is standing at 15.32% during that period while stretching the period over a month that decreases to 14.80%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 49.36 which implies that the stock is in neutral territory.
Over the week, CDIO’s stock price is moving 12.95% up while it is -15.79% when we observe its performance for the past one month. Year-to-date it is -57.48% down and over the past year, the stock is showing a downside performance of -62.15%.
The company is expected to be releasing its next quarterly report on 2025-Mar-19, for which analysts forecasted an EPS of -0.06 while estimate for next year EPS is -0.23. Moreover, analysts are in estimates of $50k for current-quarter revenue.
Currently, Cardio Diagnostics Holdings Inc’s total number of outstanding shares is 52.15M. Company’s return on investment (ROI) stands at -83.97% and return on equity (ROE) at -133.96%. Stock’s beta reads 3.50. Stock has a price to book (P/B) ratio of 1.87 while price to sale or P/S ratio amounts to 677.80. Its return on asset (ROA) is -111.20% on average.
